Advertisement

Topics

Citigroup Inc. Lowers Teva Pharmaceutical Industries Limited (TEVA) to Neutral

07:54 EDT 20 Aug 2017 | Topix

The brokerage currently has $19.00 price objective on the stock, down from their prior price objective of $32.00. TEVA has been the subject of several other reports.

Original Article: Citigroup Inc. Lowers Teva Pharmaceutical Industries Limited (TEVA) to Neutral

NEXT ARTICLE

More From BioPortfolio on "Citigroup Inc. Lowers Teva Pharmaceutical Industries Limited (TEVA) to Neutral"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...